These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 24280021)

  • 21. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ; Siuda J
    Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low serum uric acid levels in progressive supranuclear palsy.
    Oropesa-Ruiz JM; Huertas-Fernández I; Jesús S; Cáceres-Redondo MT; Vargas-Gonzalez L; Carrillo F; Carballo M; Gómez-Garre P; Mir P
    Mov Disord; 2016 Mar; 31(3):402-5. PubMed ID: 26686202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Bukhatwa S; Zeng BY; Rose S; Jenner P
    Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential of a new MRI for visualizing cerebellar involvement in progressive supranuclear palsy.
    Hara K; Watanabe H; Ito M; Tsuboi T; Watanabe H; Nakamura R; Senda J; Atsuta N; Adachi H; Aiba I; Naganawa S; Sobue G
    Parkinsonism Relat Disord; 2014 Feb; 20(2):157-61. PubMed ID: 24172606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies.
    Constantinescu R; Andreasson U; Holmberg B; Zetterberg H
    Acta Neurol Scand; 2013 Feb; 127(2):e8-12. PubMed ID: 22998191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy.
    Holmberg B; Johnels B; Blennow K; Rosengren L
    Mov Disord; 2003 Feb; 18(2):186-90. PubMed ID: 12539213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
    Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations.
    Kroonenberg PM; Oort FJ; Stebbins GT; Leurgans SE; Cubo E; Goetz CG
    BMC Med Res Methodol; 2006 Jun; 6():26. PubMed ID: 16772027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortical thickness, surface area and volume measures in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Worker A; Blain C; Jarosz J; Chaudhuri KR; Barker GJ; Williams SC; Brown R; Leigh PN; Simmons A
    PLoS One; 2014; 9(12):e114167. PubMed ID: 25463618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum metabolomics study in a group of Parkinson's disease patients from northern India.
    Nagesh Babu G; Gupta M; Paliwal VK; Singh S; Chatterji T; Roy R
    Clin Chim Acta; 2018 May; 480():214-219. PubMed ID: 29474999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
    Krishnan S; Mathuranath PS; Sarma S; Kishore A
    Neurol India; 2006 Sep; 54(3):268-72. PubMed ID: 16936386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.
    De Pablo-Fernández E; Courtney R; Warner TT; Holton JL
    JAMA Neurol; 2018 Aug; 75(8):1008-1012. PubMed ID: 29710120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of nocturnal blood pressure fall in various extrapyramidal syndromes.
    Schmidt C; Berg D; ; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Reichmann H; Ziemssen T
    Mov Disord; 2009 Oct; 24(14):2136-42. PubMed ID: 19768815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enteric GFAP expression and phosphorylation in Parkinson's disease.
    Clairembault T; Kamphuis W; Leclair-Visonneau L; Rolli-Derkinderen M; Coron E; Neunlist M; Hol EM; Derkinderen P
    J Neurochem; 2014 Sep; 130(6):805-15. PubMed ID: 24749759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum adiponectin levels between patients with Parkinson's disease and those with PSP.
    Kataoka H; Sugie K
    Neurol Sci; 2020 May; 41(5):1125-1131. PubMed ID: 31897945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
    Pellecchia MT; Longo K; Manfredi M; Lucetti C; Cossu G; Petrone A; Marconi R; Sensi M; Epifanio A; Eleopra R; Marchese R; Scaravilli T; Morgante L; Abbruzzese G; Bonuccelli U; Donati E; Pivonello R; Colao A; Barone P
    Mov Disord; 2008 Jan; 23(2):190-4. PubMed ID: 18044703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.